Management of ALL in Adults: 2024 ELN Recommendations

Henrik Hjorth-Hansen, Professor, Head of Department of Hematology, St Olavs Hospital HF, Trondheim, Norway, presents the ELN recommendations. The new recommendation summarizes treatment approaches for acute lymphoblastic leukemia, including the use of new immunotherapies, application of minimal residual disease for treatment decisions, management of specific subgroups, and challenging treatment situations as well as late effects and supportive care. In this MEDtalk, Henrik Hjorth-Hansen presents some of the discussion and gives his perspective.